When depression outlasts the first prescriptions: a Wentzville FAQ
Whether it is normal for antidepressants to miss, what treatment-resistant means, options beyond another pill, cost, and the drive.
If you are reading this, there is a decent chance you have already tried the obvious thing. You saw a doctor, you got a prescription, you took it faithfully. Maybe you tried a second one. And the fog is still there.
These are the questions people in Wentzville and the surrounding towns ask most at that point, answered as plainly as we can. Our numbers come from a paid survey of 443 Midwest adults and are final.
Is it normal for antidepressants not to work?
It is common, which is not quite the same as normal, but it should take some of the shame out of it. Nearly three quarters of those we surveyed, 72 percent, said standard medication had failed them or someone close against depression, anxiety, or PTSD. Only 28 percent had no such experience.
So if the pills have not done enough, you are describing the experience of most people who answered our survey, not a rare malfunction.
What does "treatment-resistant depression" mean?
Many doctors apply the term once two or more antidepressants, each at a fair dose and for a fair trial period, have left depression largely in place. It describes how the illness has responded, not anything about you as a person. Insurers lean on the label, too, before approving more specialized care.
How do I know if that applies to me?
This is not a puzzle to solve by yourself. Bring your medication history to your doctor: the names, doses, the length of each trial, and the reason you quit. Then ask directly whether your history meets the definition. Some trials may not count if they were too short or at too low a dose, and your doctor can tell you.
Who do people usually talk to first?
Their regular doctor. A primary care physician is where 56 percent of our respondents would begin, and about a quarter with a psychiatrist. As the push to try a new treatment, their own doctor's word beat every other source combined, at 74 percent.
If you have a primary care doctor in Wentzville or nearby, that visit is the most natural starting line.
What options are there besides another pill?
More than most people realize. Depending on your situation, a clinician might talk with you about:
- A different medication or an added one to boost the first.
- Structured therapy, often alongside other treatment.
- TMS, a treatment using magnetic pulses, with no medication involved.
- Esketamine nasal spray (Spravato), which has FDA approval for adults with depression that standard treatment has not resolved.
Which of these fits is a clinical decision for you and your provider. The point is that the list is longer than the one you have already worked through. This overview of Spravato explains the esketamine option in plain terms.
Why have I never heard of Spravato?
You are in good company. Seventy-three percent of the people in our survey had never heard the name, and about a fifth recognized it without knowing what it does. A mere 6 percent could describe it.
Is it the same as the ketamine I see advertised online?
No. Esketamine, in its Spravato form, is taken at a certified clinic while staff supervise, and you stay for monitoring before you leave. You are not allowed to drive yourself home on treatment days.
Ketamine offered for depression by IV infusion or at-home programs is off-label, because ketamine has no FDA approval for depression. At-home options in particular involve much less supervision. These are separate choices with separate safeguards, and it is worth asking a clinician about the difference before considering either.
Do I have to go all the way into St. Louis for this kind of care?
Not necessarily, but you should check before you commit. Specialized clinics are not on every corner, and Wentzville sits at the far western end of the county. Distance matters: 43 percent of our respondents counted "close to home" among their top two, behind only insurance.
Ask your doctor where they refer patients, then map the drive at the time you would actually be going. Some treatments involve multiple visits a week early on. Shift workers should ask about early or late times up front.
What will it cost?
That depends entirely on your coverage. It was also the biggest concern in our data: 85 percent ranked insurance among the two biggest factors when picking a provider, and coverage would sway 65 percent heavily, as the deciding or a big factor, on whether to try the treatment at all.
Before booking, phone your insurer. Find out if the treatment is on the plan, if prior authorization applies, and which providers near Wentzville are in network.
Should I pay out of pocket to go faster?
Some people do. Just over half of our respondents would stay with insurance even with extra hoops; 23 percent would pay to keep things simple, and 26 percent were unsure. Know that off-label ketamine programs are more often cash-pay, and ask detailed questions about oversight if you go that direction.
I am skeptical of all this. Is that okay?
Absolutely. About a fifth of our respondents were skeptical on first hearing of ketamine therapy, and a larger group, a third, were cautious but open. Skepticism is a healthy start for any medical decision. Bring your doubts to your doctor. A good one will answer them rather than wave them off.
What should I do this week?
- Write down your medication history.
- Book an appointment specifically to discuss your depression.
- Call your insurer to learn what is covered.
- Tell one person you trust what is going on.
If the hopelessness has turned into thinking about ending your life, please reach out before any appointment. The Suicide and Crisis Lifeline takes texts and calls at 988 from Wentzville or anywhere else, around the clock; veterans can press 1. Trained people answer.
Methodology
Our figures come from Pollfish's consumer panel, where our questionnaire was open until June 23, 2026. The 443 respondents, adults 18 to 64, lived in Iowa, Kansas, Illinois, Minnesota, Missouri, Nebraska, Oklahoma, Wisconsin, Ohio, and Indiana. We cite top-line results and nothing narrower. Percentages reflect the panel after its validation was final. The survey was paid for by the publisher, who commissioned it. None of this is medical advice.